IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

BIT:IVG • NL0015000LU4

19.15 EUR
+0.02 (+0.1%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

IVG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 107 industry peers in the Machinery industry. IVG has a medium profitability rating, but doesn't score so well on its financial health evaluation. IVG may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year IVG was profitable.
  • IVG had a positive operating cash flow in the past year.
  • IVG had positive earnings in each of the past 5 years.
  • IVG had a positive operating cash flow in each of the past 5 years.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • IVG has a worse Return On Assets (1.48%) than 63.96% of its industry peers.
  • With a decent Return On Equity value of 10.01%, IVG is doing good in the industry, outperforming 64.86% of the companies in the same industry.
  • IVG's Return On Invested Capital of 4.17% is on the low side compared to the rest of the industry. IVG is outperformed by 61.26% of its industry peers.
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROIC 4.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • IVG has a worse Profit Margin (1.82%) than 64.86% of its industry peers.
  • IVG's Profit Margin has improved in the last couple of years.
  • IVG has a Operating Margin of 4.33%. This is in the lower half of the industry: IVG underperforms 62.16% of its industry peers.
  • In the last couple of years the Operating Margin of IVG has grown nicely.
  • IVG has a worse Gross Margin (16.00%) than 91.89% of its industry peers.
  • In the last couple of years the Gross Margin of IVG has grown nicely.
Industry RankSector Rank
OM 4.33%
PM (TTM) 1.82%
GM 16%
OM growth 3Y5.55%
OM growth 5YN/A
PM growth 3Y27.65%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVG is destroying value.
  • IVG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.75, we must say that IVG is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of IVG (1.75) is comparable to the rest of the industry.
  • The Debt to FCF ratio of IVG is 9.94, which is on the high side as it means it would take IVG, 9.94 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 9.94, IVG is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.29 is on the high side and indicates that IVG has dependencies on debt financing.
  • The Debt to Equity ratio of IVG (1.29) is worse than 83.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Altman-Z 1.75
ROIC/WACC0.57
WACC7.3%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • IVG has a Current Ratio of 1.91. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • IVG has a Current ratio of 1.91. This is in the better half of the industry: IVG outperforms 68.47% of its industry peers.
  • A Quick Ratio of 1.38 indicates that IVG should not have too much problems paying its short term obligations.
  • IVG has a Quick ratio of 1.38. This is in the better half of the industry: IVG outperforms 78.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.38
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for IVG have decreased strongly by -44.23% in the last year.
  • The Earnings Per Share has been growing by 34.20% on average over the past years. This is a very strong growth
  • The Revenue has decreased by -8.94% in the past year.
  • The Revenue has been growing slightly by 5.22% on average over the past years.
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.30% on average over the next years. This is a very strong growth
  • IVG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.30% yearly.
EPS Next Y83.33%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
EPS Next 5YN/A
Revenue Next Year8.41%
Revenue Next 2Y7.34%
Revenue Next 3Y8.3%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.51, which indicates a correct valuation of IVG.
  • Based on the Price/Earnings ratio, IVG is valued a bit cheaper than 77.48% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.07. IVG is valued slightly cheaper when compared to this.
  • IVG is valuated reasonably with a Price/Forward Earnings ratio of 9.00.
  • Based on the Price/Forward Earnings ratio, IVG is valued cheaper than 91.89% of the companies in the same industry.
  • IVG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.05.
Industry RankSector Rank
PE 16.51
Fwd PE 9
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 74.77% of the companies listed in the same industry.
  • IVG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IVG is cheaper than 79.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.83
EV/EBITDA 6.43
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • IVG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as IVG's earnings are expected to grow with 39.30% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y50.33%
EPS Next 3Y39.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.73%, IVG has a reasonable but not impressive dividend return.
  • IVG's Dividend Yield is a higher than the industry average which is at 1.45.
  • IVG's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.73%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • IVG pays out 33.46% of its income as dividend. This is a sustainable payout ratio.
DP33.46%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IVECO GROUP NV

BIT:IVG (2/27/2026, 7:00:00 PM)

19.15

+0.02 (+0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.19B
Revenue(TTM)13.92B
Net Income(TTM)263.00M
Analysts70.77
Price Target20.11 (5.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.73%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP33.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.41%
Min EPS beat(2)-69.38%
Max EPS beat(2)-15.44%
EPS beat(4)2
Avg EPS beat(4)-3.86%
Min EPS beat(4)-69.38%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)11.85%
EPS beat(12)7
Avg EPS beat(12)5.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-10.33%
Max Revenue beat(2)8.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-10.33%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.3%
Revenue beat(12)6
Avg Revenue beat(12)0.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-4.26%
Valuation
Industry RankSector Rank
PE 16.51
Fwd PE 9
P/S 0.36
P/FCF 8.83
P/OCF 3.66
P/B 1.98
P/tB 7.98
EV/EBITDA 6.43
EPS(TTM)1.16
EY6.06%
EPS(NY)2.13
Fwd EY11.11%
FCF(TTM)2.17
FCFY11.32%
OCF(TTM)5.23
OCFY27.32%
SpS53.38
BVpS9.69
TBVpS2.4
PEG (NY)0.2
PEG (5Y)N/A
Graham Number15.9
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROCE 5.15%
ROIC 4.17%
ROICexc 5.08%
ROICexgc 6.33%
OM 4.33%
PM (TTM) 1.82%
GM 16%
FCFM 4.06%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.55%
OM growth 5YN/A
PM growth 3Y27.65%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Debt/EBITDA 2.49
Cap/Depr 112.3%
Cap/Sales 5.74%
Interest Coverage 250
Cash Conversion 103.8%
Profit Quality 223.57%
Current Ratio 1.91
Quick Ratio 1.38
Altman-Z 1.75
F-Score6
WACC7.3%
ROIC/WACC0.57
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)159.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
EPS Next Y83.33%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%
Revenue Next Year8.41%
Revenue Next 2Y7.34%
Revenue Next 3Y8.3%
Revenue Next 5YN/A
EBIT growth 1Y-33.08%
EBIT growth 3Y3.22%
EBIT growth 5YN/A
EBIT Next Year125.49%
EBIT Next 3Y46.05%
EBIT Next 5YN/A
FCF growth 1Y93.42%
FCF growth 3Y7.24%
FCF growth 5Y37.52%
OCF growth 1Y12%
OCF growth 3Y-17.96%
OCF growth 5Y6.81%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


What is the valuation status for IVG stock?

ChartMill assigns a valuation rating of 7 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Undervalued.


Can you provide the profitability details for IVECO GROUP NV?

IVECO GROUP NV (IVG.MI) has a profitability rating of 4 / 10.


How financially healthy is IVECO GROUP NV?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


Can you provide the expected EPS growth for IVG stock?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to grow by 83.33% in the next year.